Table 1.
Annual Estimated Number of Adults with Treatment for Skin Cancer and Other Cancers in the U.S.
| All skin cancer (melanoma or nonmelanoma) |
Nonmelanoma skin cancer | Melanoma skin cancer | All cancer sites (excluding skin cancer) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2002–2006, n (SE) |
2007–2011, n (SE) |
p- valuea |
2002–2006, n (SE) |
2007–2011, n (SE) |
p- valuea |
2002–2006, n (SE) |
2007–2011, n (SE) |
p- valuea |
2002–2006, n (SE) |
2007–2011, n (SE) |
p- valuea |
|
| Persons with cancer treatment |
3,419,507 (170,507) | 4,914,910 (243,528) | <0.001 | 3,090,442 (154,887) | 4,301,338 (224,361) | <0.001 | 372,536 (44,081) | 700,647 (59,659) | <0.001 | 7,809,643 (236,563) | 10,345,779 (311,917) | <0.001 |
| % (SE) | % (SE) | % (SE) | % (SE) | % (SE) | % (SE) | % (SE) | % (SE) | |||||
| PERCENT WITH CANCER TREATMENT | ||||||||||||
| Aged ≥18 years | ||||||||||||
| Male and female | 1.55 (0.07) | 2.12 (0.09) | <0.001 | 1.40 (0.06) | 1.85 (0.09) | <0.001 | 0.17 (0.02) | 0.30 (0.03) | <0.001 | 3.55 (0.08) | 4.46 (0.10) | <0.001 |
| Male | 1.76 (0.10) | 2.40 (0.12) | <0.001 | 1.58 (0.09) | 2.12 (0.12) | <0.001 | 0.21 (0.03) | 0.32 (0.04) | 0.019 | 3.14 (0.12) | 4.07 (0.15) | <0.001 |
| Female | 1.36 (0.08) | 1.85 (0.11) | <0.001 | 1.24 (0.08) | 1.60 (0.10) | 0.003 | 0.13 (0.02) | 0.28 (0.03) | <0.001 | 3.92 (0.11) | 4.83 (0.13) | <0.001 |
| Age 18–64 years | ||||||||||||
| Male and female | 0.81 (0.05) | 0.94 (0.06) | 0.081 | 0.70 (0.04) | 0.79 (0.05) | 0.202 | 0.11 (0.02) | 0.17 (0.02) | 0.068 | 2.26 (0.06) | 2.74 (0.08) | <0.001 |
| Male | 0.84 (0.07) | 0.89 (0.08) | 0.617 | 0.72 (0.05) | 0.77 (0.07) | 0.56 | 0.13 (0.03) | 0.12 (0.02) | 0.874 | 1.55 (0.08) | 1.97 (0.10) | 0.001 |
| Female | 0.78 (0.07) | 0.99 (0.08) | 0.042 | 0.68 (0.06) | 0.80 (0.07) | 0.194 | 0.10 (0.02) | 0.21 (0.03) | 0.006 | 2.96 (0.10) | 3.48 (0.13) | 0.001 |
| Aged ≥65 years | ||||||||||||
| Male and female | 5.23 (0.27) | 7.66 (0.35) | <0.001 | 4.87 (0.26) | 6.86 (0.32) | <0.001 | 0.44 (0.06) | 0.94 (0.11) | <0.001 | 9.87 (0.31) | 12.56 (0.37) | <0.001 |
| Male | 7.01 (0.47) | 10.53 (0.53) | <0.001 | 6.46 (0.45) | 9.34 (0.49) | <0.001 | 0.67 (0.11) | 1.38 (0.20) | 0.002 | 12.17 (0.53) | 15.31 (0.70) | <0.001 |
| Female | 3.89 (0.31) | 5.46 (0.36) | 0.001 | 3.67 (0.30) | 4.97 (0.35) | 0.004 | 0.26 (0.06) | 0.61 (0.12) | 0.011 | 8.15 (0.41) | 10.46 (0.40) | <0.001 |
Note: Boldface indicates statistical significance (p<0.05). Estimates are based on weighted data from the 2002–2011 Medical Expenditure Panel Survey. Estimates of persons treated for “all skin cancers” are slightly lower than the sum of nonmelanoma and melanoma because a small number of persons were reported as treated for both types.
a
Difference from 2002–2006 and 2007–2011.